Ask the Expert: How to generate a high-producing cell line on a reduced timeline?

Learn from Research BDS Scientist Lucie Grindes from our Biodevelopment Center France, about our mini-pool approach and how we can begin process development in parallel with cell line development, for customers on a very challenging timeline.

Read our case study: Accelerate the Time from DNA to Material https://bit.ly/2VI3BFi

Watch the Webinar: Straight to the Point: Reaching Clinical Stage Development with a CHOZN® Cell Line https://bit.ly/35EjEIM

Let’s explore how our semi-automated mini-pool approach enables more rapid and efficient selection of high-producing cell lines, accelerates upstream processes, saving approximately 3 months.

Are you a small-sized biotech? Learn about our Plug & Play Upstream Development Service at https://www.MerckMillipore.com/plug-p...

BioReliance® End-to-End Solutions

BioReliance® End-to-End Solutions is an adaptable CDMO partner for small biotechs and start-ups needing to develop and commercialize biologics. We do this by balancing speed, risk and cost through custom solutions, by leveraging our bioprocessing technologies and process development expertise, and by allowing our clients to transfer their process and knowledge to their end point at any step of their drug development. To learn more, please visit https://www.MerckMillipore.com/adapti...